Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC

Clinical trial NCT04912765 · RECRUITING

Trial details

NCT number: NCT04912765
Sponsor: National Cancer Centre, Singapore
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Hepatocellular Cancer Colorectal Cancer Colorectal Carcinoma Liver Metastases

Start date: 2021-04-15
Primary completion: 2026-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.